|
|
 |
|
Viewing report
|
|
|
|
Krka DD Novo Mesto
Wright Investors' Service, May 2009, Pages: 41
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Krka DD Novo Mesto. There is a textual review of the financial results of Krka DD Novo Mesto versus Farmacol SA, Ipsen and Alapis S.A.. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Krka DD Novo Mesto are the Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and Key Data Items (Ticker, Major Industry, Sub-Industry, Fiscal Year End Month, Employees, Share Type, Market Capitalization, Total Shares Outstanding and Number of Closely Held Shares.) Additional research for Krka DD Novo Mestoincludes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Novo Nordisk As
Sava DD
Istrabenz DD
Gorenje Gospodinjski Aparati dd
Pivovarna Lasko DD
Telekom Slovenije DD
Luka Koper, d.d.
Novo Nordisk AS - Financial and Strategic Analysis Review
KrKa d.d. Novo Mesto 2006 Annual Report
Novo Nordisk A/S Medical Equipment Company Share Analysis 2008
Krka Generics Company Intelligence Report
Labod Novo Mesto d.d. (Slovenia) - Company Profile
|
|
|
|
